Pierre Claver Kayumba

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Paul N. Newton, Katherine C. Bond, Moji Christianah Adeyeye et al. · The Lancet Global Health · 2020 · 167 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10

Quinine sulphate pellets for flexible pediatric drug dosing: Formulation development and evaluation of taste-masking efficiency using the electronic tongue

Pierre Claver Kayumba, Nathalie Huyghebaert, Christophe Cordella et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2006 · 104 citations

Pharmacy, Pediatric Pharmacy, Pharmacology +17

Global access to quality-assured medical products: the Oxford Statement and call to action

Paul N. Newton, Katherine C. Bond, Paul N. Newton et al. · The Lancet Global Health · 2019 · 56 citations · Full text

Pharmacy, Pharmaceutical Policy, Global Health +15

Prices, availability and affordability of medicines in Rwanda

Thomas Bizimana, Pierre Claver Kayumba, Lutz Heide · PLoS ONE · 2020 · 53 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +13

The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution

Pierre Claver Kayumba, P. G. Risha, Danstan H. Shewiyo et al. · Journal of Clinical Pharmacy and Therapeutics · 2004 · 49 citations

Pharmacy, Pharmaceutics, Pharmacology +17